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Abstract
Introduction: Several aspects of the epidemiology of 2009 (H1N1) pandemic influenza have not been accurately
determined. We sought to study whether the age distribution of cases differs in comparison with seasonal influenza.
Methods: We searched for official, publicly available data through the internet from different countries worldwide on
the age distribution of cases of influenza during the 2009 (H1N1) pandemic influenza period and most recent
seasonal influenza periods. Data had to be recorded through the same surveillance system for both compared
periods.
Results: For 2009 pandemic influenza versus recent influenza seasons, in USA, visits for influenza-like illness to
sentinel providers were more likely to involve the age groups of 5–24, 25–64 and 0–4 years compared with the
reference group of .64 years [odds ratio (OR) (95% confidence interval (CI)): 2.43 (2.39–2.47), 1.66 (1.64–1.69), and
1.51 (1.48–1.54), respectively]. Pediatric deaths were less likely in the age groups of 2–4 and ,2y e a r st h a nt h e
reference group of 5–17 years [OR (95% CI): 0.46 (0.25–0.85) and 0.49 (0.30–0.81), respectively]. In Australia,
notifications for laboratory-confirmed influenza were more likely in the age groups of 10–19, 5–9, 20–44, 45–64 and
0–4 years than the reference group of .65 years [OR (95% CI): 7.19 (6.67–7.75), 5.33 (4.90–5.79), 5.04 (4.70–5.41), 3.12
(2.89–3.36) and 1.89 (1.75–2.05), respectively]. In New Zealand, consultations for influenza-like illness by sentinel
providers were more likely in the age groups of ,1, 1–4, 35–49, 5–19, 20–34 and 50–64 years than the reference
group of .65 years [OR (95% CI): 2.38 (1.74–3.26), 1.99 (1.62–2.45), 1.57 (1.30–1.89), 1.57 (1.30–1.88), 1.40 (1.17–1.69)
and 1.39 (1.14–1.70), respectively].
Conclusions: The greatest increase in influenza cases during 2009 (H1N1) pandemic influenza period, in comparison with
most recent seasonal influenza periods, was seen for school-aged children, adolescents, and younger adults.
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Introduction
Since the spring of 2009, the globe has witnessed an influenza
pandemic due to a variant H1N1 influenza virus [1]. The initial
public health guidance and response was inevitably based on the
evidence obtained from previous influenza pandemics. Subse-
quently, a wealth of information collected from various sources
worldwide regarding the main epidemiological characteristics,
clinical manifestations, and outcome of the new influenza
pandemic has rapidly accumulated [2]. However, several
important aspects of the true impact of 2009 (H1N1) pandemic
influenza have not been accurately determined to guide
appropriate public health responses [3].
In this regard, we sought to explore the differences between
the 2009 (H1N1) pandemic influenza period and recent
seasonal influenza periods regarding the age distribution of
influenza cases.
Methods
We searched, up to March 2010, in the official websites of
major health organizations or institutions worldwide for publicly
available surveillance data on the age distribution of influenza
cases. Specifically, we searched in the websites of the World
Health Organization, the European Centre for Disease Prevention
and Control, the United Kingdom Health Protection Agency and
Office of National Statistics, the French Institute for Public Health
Surveillance, the Swedish Institute for Communicable Disease
Control, the United States Centers for Disease Control and
Prevention (CDC) and the Department of Defense Global
Emerging Infections Surveillance and Response System, the
Public Health Agency of Canada, the Australian Government
Department of Health and Ageing and the National Notifiable
Diseases Surveillance System, the New Zealand Ministry of Health
and the Institute of Environmental Science and Research, the
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Pan American Health Organization, the Argentinean Ministry of
Health, the Mexican Department of Health, the Chilean Ministry
of Health, and the Brazilian Ministry of Health. We also searched
for additional relevant influenza surveillance data, through web
links from the above websites. Finally, we retrieved official data on
the type and antigenic characterization of circulating influenza
viruses during each influenza season and country analyzed.
We included in our analysis epidemiological data referring to
the 2009 (H1N1) pandemic influenza period (from mid April
2009 until the end of 2009) and one or more of the most recent
influenza seasons, provided that they were recorded with the
same surveillance system and similar methodology. We included
data on influenza cases that had been diagnosed either clinically
or with appropriate relevant laboratory methods, regardless of
the level of health-care they received. We synthesized the
retrieved data into meaningful and comparable age groups. We
calculated the percentage of cases in the different age groups for
both the pandemic and the seasonal influenza periods. We
constructed graphical representations of the percentile distribu-
tion of cases into age groups between the pandemic and,
cumulatively, the seasonal influenza periods. We also calculated
the percentage difference in the recorded number or rate of cases,
between the pandemic and the seasonal influenza periods, for
each age group.
Statistical analysis
We compared the distribution of cases into age groups
between the pandemic and, cumulatively, the seasonal
influenza periods, using the chi-square test. A p value ,0.05
was considered statistically significant. We also calculated the
odds ratio (OR) and 95% confidence interval (CI) for a case of
i n f l u e n z at ob e l o n gt oe a c hs p e cific age group compared with a
reference age group, between the pandemic and, cumulatively,
the seasonal influenza periods. We used the older age group in
each dataset as the reference group. For the above analyses, we
used the SPSS Statistics v.17.0 software (SPSS Inc., Chicago,
IL).
Results
We identified comparable data on the age distribution of
influenza cases between the 2009 (H1N1) pandemic period and
most recent seasonal influenza periods that were provided by the
CDC, the Australian Government Department of Health and
Ageing, and the New Zealand Institute of Environmental Science
and Research. In Tables 1, 2, 3, 4, 5, we present the actual data
that we retrieved and combined into age groups. We also present
official data on the prevalence of different viral types and
subtypes that circulated during each of the seasonal influenza
periods and country evaluated. Additionally, we present in
Tables 1, 2, 3, 4, 5 and in Figures 1, 2, 3, 4, the percentile
distribution of cases into different age groups for both the
pandemic and the compared seasonal influenza periods. More-
over, we present the percentage difference between the absolute
number of the recorded influenza cases (or rate per unit of
population) between the pandemic influenza period and the
average for the seasonal influenza periods. Finally, the odds ratio
for a case of influenza to belong to each specific age group
compared with the reference group in the pandemic versus the
seasonal influenza periods is also shown in Tables 1, 2, 3, 4, 5.
More specific data are presented below, according to the type of
influenza diagnosis and severity of cases.
Unselected laboratory-confirmed cases of influenza
In Australia, the National Notifiable Diseases Surveillance
System provided data regarding the number of cases of laboratory-
confirmed influenza (Table 1). In 2009 (pandemic influenza
period) the cases of laboratory-confirmed influenza (total of 45032)
increased by 491% compared with the average number of those
recorded during the 3 preceding seasonal influenza periods (2006–
2008; average of 7614 per year). The distribution of influenza
cases into age groups differed between the pandemic influenza
period and the seasonal influenza periods combined (P,0.001;
Figure 1). For the pandemic influenza period versus the seasonal
influenza periods, a case of influenza was more likely to belong
into the age group of 10–19 years (OR: 7.19, 95% CI: 6.67–7.75),
5–9 years (OR: 5.33, 95% CI: 4.90–5.79), 20–44 years (OR: 5.04,
95% CI: 4.70–5.41), 45–64 years (OR: 3.12, 95% CI: 2.89–3.36),
and 0–4 years (OR: 1.89, 95% CI: 1.75–2.05) compared with the
reference age group of those more than 65 years.
Cases of influenza-like illness
In New Zealand, the Institute of Environmental Science and
Research, a governmental research institute, provided data
regarding the average weekly consultation rate for influenza-like
illness in sentinel practices per 100000 patient population reported
by these practices (Table 2). In 2009 (pandemic influenza period)
the average weekly sentinel consultation rate for influenza-like
illness (77.9 per 100000 patient population) increased by 48.7%
compared with 2008 (seasonal influenza period; 52.4 per 100000
patient population). Figure 2 presents the average weekly
consultation rate for influenza-like illness in sentinel practices by
age group, adjusted to the respective consultation rate for the total
population, for 2009 in comparison with 2008.
We used the above presented data on the average weekly
sentinel consultation rate for influenza-like illness in New Zealand
to approximately calculate the absolute number of cases of
influenza-like illness reported by the sentinel practices during the
pandemic and seasonal influenza periods that we evaluated
(Table 2). Specifically, we multiplied the age-specific weekly
consultation rate by the total number of weeks that influenza
surveillance was in effect for each influenza period (36 weeks for
2009 and 23 weeks for 2008) and the total age-specific patient
population examined in the sentinel practices. According to the
official reports by the New Zealand Institute of Environmental
Science and Research, the total age-specific patient population
examined in the sentinel practices was not recorded, but derived
from the total patient-population examined in these practices
(402884 for 2009 and 333150 for 2008), assuming that it had the
same age distribution as the New Zealand general population,
according to the census data. We used relevant data from the 2006
New Zealand census in this regard.
The distribution of influenza-like illness cases into age groups
differed between the 2009 pandemic influenza period and the
2008 seasonal influenza period (P,0.001). For the pandemic
influenza period versus the seasonal influenza period, a case of
influenza was more likely to belong into the age group of less than
1 year (OR: 2.38, 95% CI: 1.74–3.26), 1–4 years (OR: 1.99, 95%
CI: 1.62–2.45), 35–49 years (OR: 1.57, 95% CI: 1.30–1.89), 5–19
years (OR: 1.57, 95% CI: 1.30–1.88), 20–34 years (OR: 1.40, 95%
CI: 1.17–1.69), and 50–64 years (OR: 1.39, 95% CI: 1.14–1.70),
compared with the reference group of those more than 65 years.
In the United States of America (USA), the CDC provided data
regarding the number of visits to sentinel providers for influenza-
like illness (Table 3). During the 2009 (H1N1) pandemic influenza
period visits to sentinel providers for influenza-like illness
(n=923656) increased by 180% compared with the average of
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influenza periods (2008–09 and 2007–08, respectively, average
of 330401 visits per year). The distribution of visits for influenza-
like illness to sentinel providers differed between the 2009
pandemic influenza period and the 2008 seasonal influenza period
(P,0.001; Figure 3). For 2009 versus the 2007 and 2008 influenza
seasons combined, a case of influenza-like illness recorded by
sentinel providers was more likely to belong in the age group of 5–
24 years (OR: 2.43, 95% CI: 2.39–2.47), 25–64 years (OR: 1.66,
95% CI: 1.64–1.69), and 0–4 years (OR: 1.51, OR: 1.48–1.54)
compared with the reference age group of those more than 64
years (OR: 0.515, 95% CI: 0.506–0.524).
Cases hospitalized with influenza
In the USA, the CDC provided data regarding the laboratory-
confirmed influenza-associated hospitalization rate for the general
population (Table 4). Relevant data for the 2009 (H1N1)
pandemic influenza period were separately reported for the period
between 15 April – 29 August 2009 and the period between 1 Sep
2009 – 2 Jan 2010. This was related to a change in the relevant
surveillance system with addition of new sites. For the latter
period, we included surveillance data provided only by the old
sites, so that they could be directly comparable with prior relevant
surveillance data. The age distribution of cumulative laboratory-
confirmed influenza-associated hospitalization rates did not appear
to substantially differ between the two 2009 (H1N1) pandemic
influenza periods mentioned above. The highest relevant rate for
both these periods was observed in the age group of 0–4 years,
whereas rates in the remaining age groups were approximately
30–50% lower.
We compared the age distribution of laboratory-confirmed
influenza-associated hospitalization rates between the pandemic
period of 1 Sep 2009 – 2 Jan 2010 and the whole 2008–2009
influenza season, because corresponding age-specific data were
provided only for these periods. During the above-mentioned 2009
(H1N1) pandemic influenza period, compared with the 2008–
2009 seasonal influenza period, the cumulative laboratory-
confirmed influenza-associated hospitalization rate increased
primarily for the age groups of 18–49 years and 50–64 years
(increase by 667% and 625% in the hospitalization rate,
respectively); the increase in the hospitalization rate was relatively
lower for the age group of 5–17 years (380%), followed by the
groups of those more than 65 years and those up to 4 years of age
(120% and 104%, respectively). As we could not reliably retrieve
accurate data regarding the size and age distribution of the
reference population for the hospitalization rates analyzed above,
we did not proceed to calculate the respective raw hospitalization
data.
Deaths associated with influenza
In USA, the CDC provided data regarding the number of
laboratory-confirmed influenza-associated pediatric deaths
(Table 5). For the 2009 (H1N1) pandemic influenza period
relevant age-specific cumulative data were provided only for the
period of 30 August 2009 – 2 January 2010. During these last 4
months of 2009 (pandemic influenza period) laboratory-confirmed
influenza-associated pediatric deaths (n=229) increased by 203%
compared with the yearly average of the whole 2007–2008 and
2008–2009 seasonal influenza periods (average of 75.5 deaths per
year). The distribution of pediatric deaths into age groups differed
significantly between the pandemic influenza period and the
seasonal influenza periods compared (P=0.003, Figure 4). For the
pandemic influenza period versus the seasonal influenza periods
combined, pediatric deaths associated with laboratory-confirmed
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(OR: 0.46, 95% CI: 0.25–0.85) and of those less than 2 years (OR:
0.49, 95% CI: 0.30–0.81), compared with the reference group of
5–17 years.
Discussion
A common finding in the surveillance data from major national
health organizations worldwide that we identified for the purposes
of this study is that the age group of elderly individuals (more than
65 years of age) was the least one affected during the 2009 (H1N1)
pandemic influenza period, in comparison with the most recent
seasonal influenza periods. This particularly refers to laboratory-
confirmed disease incidence and presentation with influenza-like
illness to sentinel providers, according to data recorded in different
countries. Regarding the age groups mostly affected by 2009
(H1N1) pandemic influenza in comparison with the most recent
seasonal influenza periods, we noted certain differences according
to the level of influenza diagnosis (clinical or laboratory-
confirmed), the severity of cases (outpatients, hospitalized, or
deceased), and country. For 2009 (H1N1) pandemic influenza, in
comparison with seasonal influenza, laboratory-confirmed influ-
enza cases and laboratory-confirmed influenza-associated hospi-
talizations mostly increased for school-age children, adolescents,
and younger adults, according to data from Australia and USA,
respectively. Pediatric deaths associated with laboratory-confirmed
influenza increased mostly for school-age children and adolescents,
according to US data. The greatest increase in influenza-like
Table 3. Visits for influenza-like-illness reported by sentinel providers for different age groups, during the 2009 (H1N1) pandemic
influenza period and recent seasonal influenza periods, in the United States of America.*
Period Viral types and subtypes Age groups, n (%)
0–4 y 5–24 y 25–64 y .64 y
Wks 14/2009 – 52/2009 2009 (H1N1) pandemic influenza 212324 (23.0%) 475038 (51.4%) 212340 (23.0%) 23954 (2.6%)
Wks 40/2008 – 13/2009 Influenza A: 67.3% (H1N1: 89.8%,
H3N2: 10.2%), Influenza B: 32.7%
83992 (29.9%) 117573 (41.8%) 67044 (23.8%) 12212 (4.3%)
Wks 40/2007 – 20/2008 Influenza A: 71% (H1: 26%,
H3: 74%), Influenza B: 29%
106581 (28.0%) 147222 (38.7%) 105913 (27.8%) 20265 (5.3%)
Seasonal influenza periods combined 190573 (28.8%) 264795 (40.1%) 172957 (26.2%) 32477 (4.9%)
Percentage difference in the number of visits between 2009
and the average of 2008–2009 & 2007–2008 seasons
123% 259% 146% 48%
Comparison of the age distribution between pandemic
influenza and the seasonal influenza periods combined
Odds ratio (95% confidence interval) for a case of influenza to belong
to a specific age group, in the pandemic versus seasonal influenza
periods
P,0.001 1.51 (1.48–1.54) 2.43 (2.39–2.47) 1.66 (1.64–1.69) Reference
group
Abbreviations: y: years, wks: weeks.
* Data are from US Centers for Disease Control and Prevention; US Outpatient Influenza-like Illness Surveillance Network (ILINet) (http://www.cdc.gov/flu/weekly/
fluactivity.htm).
doi:10.1371/journal.pone.0021690.t003
Table 4. Laboratory-confirmed influenza-associated hospitalization rate for different age groups, during the 2009 (H1N1)
pandemic influenza period and recent seasonal influenza periods, in the United States of America.*
Period Viral types and subtypes Age groups, rate per 10000 general population
0–23 m 2–4 y 5–17 y 18–49 y 50–64 y $65 y
1 Sep 2009 – 2 Jan 2010‘ 2009 (H1N1) pandemic influenza 5.7 2.4 2.3 2.9 2.2
15 Apr 09 – 29 Aug 09 2009 (H1N1) pandemic influenza 2.4 0.9 0.8 0.5 0.6 0.5
1 Oct 2008 –28 Mar 2009 A: 67.3% (H1N1: 89.8%, H3N2:
10.2%), Influenza B: 32.7%
2.8 0.5 0.3 0.4 1.0
30 Sep 2007 – 3 May 2008 Influenza A: 71% (H1: 26%,
H3: 74%), Influenza B: 29%
4.0 0.6 NA NA NA
Percentage difference in hospitalization rate between Sep 2009 –Jan 2010 and
Oct 2008 – Mar 2009
104% 380% 667% 625% 120%
Abbreviations: m: months, NA: non-available, y: years, wks: weeks.
* Data are from US Centers for Disease Control and Prevention; Emerging Infections Program (EIP) (http://www.cdc.gov/flu/weekly/fluactivity.htm).
‘ Rates for new EIP sites are not included.
doi:10.1371/journal.pone.0021690.t004
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PLoS ONE | www.plosone.org 5 July 2011 | Volume 6 | Issue 7 | e21690illness presentations to sentinel providers was noted for school-age
children, adolescents and young adults in USA, while, in New
Zealand, this was noted for infants and preschool children.
Differences in the age distribution of cases of 2009 (H1N1)
pandemic influenza in comparison with seasonal influenza can be
attributed to differences in the degree of preexisting specific
immunity in different age groups. Specifically, elderly individuals
appear to have had protective immunity more frequently than
other age groups against the 2009 (H1N1) pandemic influenza
virus due to prior immunologic encounters with antigenically
similar viruses many years before. Increasing age has been
positively associated with the presence of cross-reactive antibodies
against the 2009 (H1N1) pandemic influenza virus, which can
prevent infection [4]. Still, specific immunity from memory T-cells
could also have been present in a substantial percentage of the
general population due to shared relevant antigenic epitopes
between 2009 (H1N1) pandemic influenza virus and recent
seasonal influenza A(H1N1) viruses and vaccine strains [5,6].
However, cellular immune responses can be relatively weak in the
elderly compared with younger individuals, and this could be
associated with higher severity of influenza once infection occurs
[7,8].
Although 2009 (H1N1) pandemic influenza, compared with
seasonal influenza, appears to have affected mainly school-age
children, adolescents, and younger adults, regarding outpatient
presentations for influenza-like illness in USA or incidence of
laboratory-confirmed disease in Australia, there appears to have
been a shift towards young and middle-aged adults for
Table 5. Laboratory-confirmed influenza-associated pediatric deaths in different age groups, during the 2009 (H1N1) pandemic
influenza period and recent seasonal influenza periods, in the United States of America.*
Period Viral types and subtypes Age groups, n (%)
,2 y 2–4 y 5–17 y
30 Aug 2009 – 2 Jan 2010 2009 (H1N1) pandemic influenza 42 (18.3%) 25 (10.9%) 162 (70.7%)
Oct 2007 – Jun 2008 Influenza A: 71% (H1: 26%,
H3: 74%), Influenza B: 29%
23 (27.7%) 18 (21.7%) 42 (50.6%)
Oct 2006 – May 2007 Influenza A: 79% (H1: 62%,
H3: 38%), Influenza B: 21%
20 (29.4%) 9 (13.2%) 39 (57.4%)
Seasonal influenza periods combined 43 (28.5%) 27 (17.9%) 81 (53.6%)
Percentage difference in pediatric deaths between Aug 2009 –
Jan 2010 and the average of 2007–2008 & 2006–2007 seasons
95% 85% 300%
Comparison of the age distribution between pandemic
influenza and the seasonal influenza periods combined
Odds ratio (95% confidence interval) for a case of influenza to
belong to a specific age group, in the pandemic versus seasonal
influenza periods
P=0.003 0.49 (0.30–0.81) 0.46 (0.25–0.85) Reference group
Abbreviations: y: years.
Data are from US Centers for Disease Control and Prevention; Influenza-Associated Pediatric Mortality Surveillance System (http://www.cdc.gov/flu/weekly/fluactivity.
htm).
doi:10.1371/journal.pone.0021690.t005
Figure 1. Percentile distribution by age group of notifications for laboratory-confirmed influenza in Australia, during 2009 (H1N1)
pandemic influenza and the 3 previous influenza seasons combined.
doi:10.1371/journal.pone.0021690.g001
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frequent co-existence of known risk factors for influenza in the
latter age groups, compared with younger patients [9]. Conditions
like pregnancy and obesity that have been associated with more
serious 2009 (H1N1) pandemic influenza requiring hospitalization
are also found more frequently among young and middle-aged
adults [10,11].
Similar observations as the ones made in our analysis regarding
a greater impact of the 2009 (H1N1) pandemic influenza on
younger patients, compared with seasonal influenza, have also
been made for other influenza pandemics [12,13]. A recent study
that comparatively evaluated the 2009 (H1N1) influenza pandem-
ic with select past seasonal H1N1 and H3N2 influenza A
epidemics in USA and France did not identify statistically
significant differences in the age distribution of the recorded
influenza-like illness cases [14]. This study found, however, that,
for the 2009 (H1N1) pandemic period, influenza-associated
mortality was higher for those younger than 60 years, particularly
for those younger than 20 years. The authors of this study
suggested that, both in seasonal influenza epidemics as well as in
influenza pandemics school-age, children have the highest contact
rates, and that during the 2009 (H1N1) influenza pandemic
mortality shifted towards those younger than 60 years of age due
to lack of preexisting protective immunity.
Similar findings regarding the impact of 2009 (H1N1) influenza
pandemic by age in terms of mortality were noted in another study
that modeled excess pneumonia & influenza mortality in the
general population in the USA during 2009–2010 and the past 47
influenza seasons [15]. For the age groups of ,15 years and 15–24
years, excess pneumonia & influenza mortality during the fall wave
of the (H1N1) 2009 influenza pandemic exceeded that of all
previous influenza seasons, including the 1968–1969 influenza
pandemic. For the age group of 25–64 years excess pneumonia
and influenza mortality during the fall wave of the 2009 (H1N1)
influenza pandemic was second only to the 1968–1969 influenza
pandemic, while for the age group of those .65 years excess
Figure 2. Adjusted sentinel average weekly consultation rate for influenza-like illness by age group in New Zealand, during 2009
(H1N1) pandemic influenza and the previous influenza season. Consultation rate by age group is shown as times X consultation rate for total
population.
doi:10.1371/journal.pone.0021690.g002
Figure 3. Percentile distribution by age group of visits for influenza-like-illness to sentinel providers, in the United States of
America, during 2009 (H1N1) pandemic influenza and the 2 previous influenza seasons combined.
doi:10.1371/journal.pone.0021690.g003
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influenza periods that H1N1 viruses predominate. An additional
study has noted that the mean age of influenza-related deaths in
the USA during the 2009 (H1N1) pandemic (37.4 years) was
considerably lower than the average for typical A/H3N2 influenza
seasons (75.7 years), as well as the 1968 and 1957 pandemics
(62.2–64.6 years), while it relatively close to the 1918 pandemic
(27.2 years) [16].
Seroprevalence studies evaluating the temporal changes in the
prevalence of antibodies against the 2009 (H1N1) pandemic
influenza virus in the community have helped in the clarification
of the evolution of the disease amongst different age groups. A
study that applied statistical modeling to evaluate sequential
seroprevalence data from England noted that during the second
wave of 2009 (H1N1) pandemic influenza (September 2009 to
February 2010) the cumulative incidence of infection was higher in
the age group of 5–14 years, followed by the age group of 1–4
years, and those of 15–24 and 25–44 years [17]. Similar findings
were noted in another study that evaluated differences in the
seroprevalence of antibodies against 2009 (H1N1) pandemic
influenza virus before and after the first wave of 2009 (H1N1)
pandemic influenza in different age groups in England [18].
Another study from New Zealand that evaluated differences in
seroprevalence data for antibodies against 2009 (H1N1) pandemic
influenza virus before and after the 2009 (H1N1) pandemic
influenza period noted that age was independently associated with
the risk of infection. Individuals in the age groups of 5–19 and 1–4
years were significantly more likely to have developed high titers of
specific antibodies compared with the reference group of 40–59
years [19]. The age distribution of influenza cases is expected to
shift to older age groups as the pandemic progresses because of
attainment of high rates of natural immunity in the younger age
groups that were hit first [20]. It should be taken into
consideration, however, that many of the seropositive cases in
the above seroprevalence studies refer to asymptomatic or
minimally symptomatic cases.
The findings of our analysis should be interpreted with caution
for several reasons. First, the recorded cases of influenza reflect
only a small subset of the actual clinical symptomatic cases, the
majority of which is not expected to seek medical care [21]. Cases
requiring admission in the intensive care unit or with a fatal
outcome were also not adequately assessed, because we did not
identify appropriate relevant data.
The comparative data we identified on the age distribution of
cases of 2009 (H1N1) pandemic influenza and seasonal influenza,
recorded by the same surveillance systems, derived from a
relatively small number of sources. The data we included referred
to developed countries (USA, Australia, and New Zealand), which
have similar socioeconomic conditions, health care systems, and
age distribution of the total population. They cannot be highly
representative of countries under development, in many of which
the life expectancy of the population is lower and the birth rate is
greater, and, thus, the percentage of younger individuals in the
population is higher. Differences between countries could also
exist regarding the epidemiology of influenza, the surveillance and
diagnostic methods used, including the definitions for syndromic
surveillance, and the attitude of the public, healthcare profession-
als and administrative organizations towards influenza [2]. The
data we analyzed refer to countries of both the northern and the
southern hemisphere, in which the first wave of the 2009 (H1N1)
pandemic influenza began in the summer and winter season,
respectively.
Apart from biological differences in the disease characteristics
[22], several factors could account for differences in influenza
surveillance data in the pandemic compared with the seasonal
influenza periods analyzed. These potentially include greater
alertness of surveillance organizations, use of better diagnostic
methods (such as real-time RT PCR instead of antigen-based
tests), increased public awareness of influenza leading to enhanced
health-seeking behavior, greater sensitivity of health care profes-
sionals in pursuing diagnosis and treatment of influenza, and
different susceptibility to antiviral drugs.
An important relevant consideration refers to potential
differences in vaccination coverage of different age groups of the
general population between the pandemic and seasonal influenza
periods. This is plausible given the differences in relevant public
health recommendations and vaccination policies. Still, for most of
the 2009 (H1N1) pandemic influenza period examined in the
context of this study, the specific influenza vaccine was not
available, and the vaccination coverage of the general population
Figure 4. Percentile distribution by age group of pediatric deaths associated with laboratory-confirmed influenza, in the United
States of America, during 2009 (H1N1) pandemic influenza and 2 previous influenza seasons combined.
doi:10.1371/journal.pone.0021690.g004
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the above-mentioned parameters could have differentially affected
different age groups in the pandemic compared with seasonal
influenza periods, and thus confound our comparative analysis, is
difficult to estimate.
An additional parameter, however, that can affect the age
distribution of seasonal influenza cases is the predominant
influenza strain in a certain region. H1 influenza A strains tend
to have greater predilection for younger individuals compared
with H3 strains, while influenza B is typically associated with
milder illness than influenza A [24]. We summed data from more
than one seasonal influenza periods, where available, so that the
influence of this parameter could be mitigated. The differences in
the predominant influenza types and subtypes during the
comparator seasonal influenza periods could explain the differ-
ences in the comparative impact of 2009 (H1N1) pandemic
influenza by age group between USA and New Zealand regarding
visits for influenza-like illness to sentinel providers observed in our
study (Tables 2–3). Finally, we should mention that we did not
adjust the actual number of influenza cases by age group to the
total population in each specific age group, because the compared
periods differed only by 1–3 years, during which the age
distribution of the population is not expected to have considerably
changed.
In conclusion, the comparative analysis of publicly available
data from 3 different countries, recorded by the same surveillance
systems, shows that during 2009 (H1N1) influenza pandemic
period the age distribution of cases shifted towards children,
adolescents, and younger adults, in comparison with recent
seasonal influenza periods. The comparative burden of the
pandemic influenza might have been greater for young and
middle-aged adults when hospitalizations are concerned. These
data could aid public health authorities to better organize
appropriate response strategies for future pandemics.
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